DGS Capital Management LLC decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,351 shares of the semiconductor company’s stock after selling 106 shares during the period. DGS Capital Management LLC’s holdings in Synopsys were worth $684,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. ORG Partners LLC lifted its stake in Synopsys by 600.0% in the second quarter. ORG Partners LLC now owns 42 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 36 shares during the last quarter. Pacifica Partners Inc. purchased a new position in shares of Synopsys during the 3rd quarter valued at $25,000. Tsfg LLC grew its stake in shares of Synopsys by 75.0% during the 3rd quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 24 shares during the period. Chris Bulman Inc purchased a new stake in Synopsys in the 2nd quarter worth about $30,000. Finally, Hazlett Burt & Watson Inc. raised its stake in Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after acquiring an additional 20 shares during the period. Institutional investors own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on SNPS. Berenberg Bank assumed coverage on shares of Synopsys in a research report on Tuesday, October 15th. They set a “buy” rating and a $660.00 target price for the company. JPMorgan Chase & Co. upped their price target on shares of Synopsys from $655.00 to $685.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Robert W. Baird decreased their price objective on Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Wells Fargo & Company started coverage on Synopsys in a report on Friday, November 22nd. They set an “equal weight” rating and a $570.00 target price for the company. Finally, Needham & Company LLC reissued a “buy” rating and set a $640.00 price target on shares of Synopsys in a research report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $649.00.
Synopsys Stock Down 0.4 %
NASDAQ SNPS traded down $1.94 on Friday, reaching $509.79. The company had a trading volume of 376,334 shares, compared to its average volume of 1,074,373. The stock has a market capitalization of $78.31 billion, a PE ratio of 35.24, a price-to-earnings-growth ratio of 3.43 and a beta of 1.08. The firm’s 50 day moving average price is $530.80 and its 200 day moving average price is $543.13. Synopsys, Inc. has a 12 month low of $457.52 and a 12 month high of $629.38.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories
- Five stocks we like better than Synopsys
- Bank Stocks – Best Bank Stocks to Invest In
- 3 Consumer Discretionary Stocks Ready for a Comeback in 2025
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Top 3 Robotics and Automation Stocks for the Next AI Boom
- What Are Earnings Reports?
- Why a Stock Split Could Be a Game-Changer for Casey’s in 2025
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.